<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPsych</journal-id><journal-title-group><journal-title>Open Journal of Psychiatry</journal-title></journal-title-group><issn pub-type="epub">2161-7325</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojpsych.2022.122012</article-id><article-id pub-id-type="publisher-id">OJPsych-116325</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Characteristics of Heroin Users in Lom&#233; (Togo)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saliou</surname><given-names>Salifou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sonia</surname><given-names>Kanekatoua</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daméga</surname><given-names>Wenkourama</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ekpao</surname><given-names>Ekpai</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Charfoundine</surname><given-names>Affo</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yao</surname><given-names>Adjévi Awoussi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kolou</surname><given-names>Simliwa Dassa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Université de Lomé, Faculté des Sciences de la Santé, Clinique Universitaire de Psychiatrie et de Psychologie Médicale, CHU Sylvanus Olympio-Lomé, H&amp;amp;#244pital Psychiatrique de Zébé-Aného, Aného, Togo</addr-line></aff><aff id="aff5"><addr-line>Clinique Médico-Psychiatrique de Lomé, Lomé, Togo</addr-line></aff><aff id="aff3"><addr-line>Université de Kara, Faculté des Sciences de la Santé, Service de Psychiatrie, CHU Kara, Kara, Togo</addr-line></aff><aff id="aff4"><addr-line>Master in Public Health, Centre Hospitalier des Armées d’Adidogomè, Lomé, Togo</addr-line></aff><aff id="aff2"><addr-line>Université de Lomé, Faculté des Sciences de la Santé, Clinique de Psychiatrie et de Psychologie Médicale, CHU Campus, Lomé, Togo</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>03</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>141</fpage><lpage>156</lpage><history><date date-type="received"><day>26,</day>	<month>February</month>	<year>2022</year></date><date date-type="rev-recd"><day>28,</day>	<month>March</month>	<year>2022</year>	</date><date date-type="accepted"><day>31,</day>	<month>March</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction:
   Opioid use is a public health problem today. The aim of this study was to describe the socio-demographic characteristics, judicial aspects, addictive behaviours and medical aspects of heroin users placed on methadone (HUM) at the Integrated Addiction Care Centre of Kodjoviakop&#233; (CEPIAK). <b>Framework and Method:</b> This was a descriptive cross-sectional study conducted at the CEPIAK in Lom&#233;, Togo, from December 1st, 2020 to January 31, 2021. <b>Results:</b> A total of 200 HUM were included in this study. They were Togolese in 89.0% of cases. Their mean age was 43.4 &#177; 9.6 years with extremes ranging from 16 to 66 years. Males accounted for 90.5% of the HUM, i.e. a sex ratio of 9.5. Primary education accounted for 39.0% of cases. Single people accounted for 44.0% of cases. One hundred and nineteen HUM (59.5%) had a history of incarceration. Cannabis, tobacco and cocaine were the other drugs associated with heroin use in 79.5%, 74.5% and 59.5% of cases respectively. A history of overdose accounted for 18.0% of the HUM in our sample. Suicide attempts accounted for 19.5% of the HUM. Tuberculosis was detected in 5.5% of the HUM. HIV accounted for 3.0% of the HUM. <b>Conclusion:</b> It is important for the Togolese health system to give more importance to this issue, which is shared by the medical and social sectors, in order to effectively reduce and prevent these social ills.
 
</p></abstract><kwd-group><kwd>Heroin</kwd><kwd> Methadone</kwd><kwd> Addictions</kwd><kwd> Comorbidities</kwd><kwd> Togo</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Opioid use is a public health issue today. In 2015, 35 million people worldwide used opioids [<xref ref-type="bibr" rid="scirp.116325-ref1">1</xref>]. They account for 70% of the negative health impacts caused by drug use and were responsible for approximately 190,000 premature deaths worldwide in 2017 [<xref ref-type="bibr" rid="scirp.116325-ref1">1</xref>]. In West Africa, opioids are increasingly available due to the transit of heroin through the region, coupled with the importation and parallel sale of potent psychotropic and analgesic drugs [<xref ref-type="bibr" rid="scirp.116325-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref3">3</xref>]. This transit of heroin and importation of powerful analgesics into West Africa has led to an increase in use and dependence, particularly among young people [<xref ref-type="bibr" rid="scirp.116325-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref3">3</xref>]. As in other West African countries, opioid-related problems have increased in Togo. For example, 32.69% of motorbike taxi drivers in Lom&#233; use tramadol [<xref ref-type="bibr" rid="scirp.116325-ref4">4</xref>]. Although the prevalence of opioid (tramadol and heroin) use in the general population in Togo is not known, health problems linked to the use of these substances have begun to be felt to the extent that an opioid substitution treatment (OST) centre was recently opened in Lom&#233; in 2019. The positive health and social impact of OST are well documented [<xref ref-type="bibr" rid="scirp.116325-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref6">6</xref>]. The objective of this study was to describe the socio-demographic characteristics, judicial aspects, addictive behaviours and medical aspects of heroin users placed on methadone at the Integrated Addiction Care Centre of Kodjoviakop&#233;.</p></sec><sec id="s2"><title>2. Framework and Method</title><sec id="s2_1"><title>2.1. Framework</title><p>The Integrated Addiction Care Centre of Kodjoviakop&#233; (CEPIAK) in Lom&#233;, Togo, served as the setting for our study.</p><p>CEPIAK is a pilot centre set up by the Abidjan-Lagos CORRIDOR Organisation (OCAL) in collaboration with the Togolese state since 2018. But it was only operational in June 2019. It is the 2nd centre of its kind in West Africa after the Integrated Addiction Care Centre of Dakar (CEPIAD). The CEPIAK raises awareness among drug users, through their mode of consumption, about the risks of transmission of diseases such as HIV, tuberculosis and Hepatitis B and C. These drug users are registered, monitored and selected for care. Some heroin users, especially injectors, are taken into care and put on methadone if necessary.</p><p>CORRIDOR is an inter-state organisation of five countries born under the initiative of the Heads of State of the countries concerned (Ivory Coast, Ghana, Togo, Benin and Nigeria). This CORRIDOR drains a migratory flow of 110 million people per year. Seeing the importance of this migratory corridor for the West African sub-region, the Heads of State have taken steps to protect this population in terms of health by setting up CORRIDOR. This sub-regional institution has set up a Border Committee for the Fight against AIDS on the eight borders crossed by the Organisation. The objectives of CORRIDOR are, among others, to facilitate the crossing of borders by people and goods and to fight against HIV/AIDS and sexually transmitted diseases at the borders. The priority targets are migrants, drivers and trainees of heavy machinery or trailers and semi-trailers, young girls and women, key populations such as sex workers, men having sex with men and injecting drug users. As the latter has an HIV prevalence rate above the national average, a risk reduction strategy for them was to set up a methadone centre, hence the creation of this pilot project, the CEPIAK. The aim of this pilot project is to offer comprehensive outpatient care to people addicted to psychoactive substances while respecting their human rights.</p></sec><sec id="s2_2"><title>2.2. Method</title><sec id="s2_2_1"><title>2.2.1. Type and Period of Study</title><p>This was a descriptive cross-sectional study conducted at the CEPIAK in Lom&#233;, Togo, from December 1st, 2020 to January 31, 2021.</p></sec><sec id="s2_2_2"><title>2.2.2. Study Population</title><p>Our study population consisted of heroin addicts of all ages and sexes who were being monitored at the CEPIAK and put on methadone. The sampling was exhaustive, while taking into account the free and informed consent of these people.</p><p>Included in this study, are those who regularly come to the CEPIAK to take their methadone dose and who had agreed to participate in the study.</p></sec><sec id="s2_2_3"><title>2.2.3. Data Collection Technique</title><p>The data was collected during the daily methadone intake. A pre-established survey form including socio-demographic aspects, legal situation, addictive behaviour and medical aspects was used. The DSM 5 was our diagnostic reference.</p></sec><sec id="s2_2_4"><title>2.2.4. Data Analysis Technique</title><p>These data were entered and processed using Epi info software version 7.2.0.1. The tables were produced using EXCEL 2013 software.</p></sec><sec id="s2_2_5"><title>2.2.5. Ethical Considerations</title><p>Patients meeting the inclusion criteria were informed about the study. A free and informed consent form was signed by each patient. Confidentiality and anonymity were respected.</p></sec></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Socio-Demographic Data</title><p>During the study period, 200 heroin users had been put on methadone and constituted our sample of 300 addicts registered at CEPIAK. Of these, 89.0% were Togolese and 11.0% were foreigners (Ghana, Benin, Nigeria, Niger, Ivory Coast and Cameroon). Their average age was 43.4 &#177; 9.6 years with extremes ranging from 16 to 66 years. The age group from 45 to 54 years represented 41.5% of heroin users put on methadone (HUM). Males accounted for 90.5% of HUM, i.e. a sex ratio of 9.5. Primary education accounted for 39.0% of cases. Single people accounted for 44.0% of cases. They were artisans in 31.5% of cases. They had no medical coverage in 97.0% of cases. These HUM were heterosexual in 99.5% of cases. <xref ref-type="table" rid="table1">Table 1</xref> summarises all socio-demographic aspects.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of HUM by socio-demographic data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Workforce (n = 200)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤34 years</td><td align="center" valign="middle"  colspan="2"  >38</td><td align="center" valign="middle" >19.0</td></tr><tr><td align="center" valign="middle" >35 - 44 years</td><td align="center" valign="middle"  colspan="2"  >61</td><td align="center" valign="middle" >30.5</td></tr><tr><td align="center" valign="middle" >45 - 54 years</td><td align="center" valign="middle"  colspan="2"  >83</td><td align="center" valign="middle" >41.5</td></tr><tr><td align="center" valign="middle" >≥55 years</td><td align="center" valign="middle"  colspan="2"  >18</td><td align="center" valign="middle" >9.0</td></tr><tr><td align="center" valign="middle" >Profession</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Artisan</td><td align="center" valign="middle"  colspan="2"  >63</td><td align="center" valign="middle" >31.5</td></tr><tr><td align="center" valign="middle" >Liberal</td><td align="center" valign="middle"  colspan="2"  >43</td><td align="center" valign="middle" >21.5</td></tr><tr><td align="center" valign="middle" >Trader/Reseller</td><td align="center" valign="middle"  colspan="2"  >36</td><td align="center" valign="middle" >18.0</td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle"  colspan="2"  >31</td><td align="center" valign="middle" >15.5</td></tr><tr><td align="center" valign="middle" >Employee</td><td align="center" valign="middle"  colspan="2"  >23</td><td align="center" valign="middle" >11.5</td></tr><tr><td align="center" valign="middle" >Pupil/student</td><td align="center" valign="middle"  colspan="2"  >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Professional situation during the year of the last 6 months</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Informal employment</td><td align="center" valign="middle" >141</td><td align="center" valign="middle" >70.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Unemployment/unemployed</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >23.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Formal employment</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Student</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Housewife</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Retirement</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Marital status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Single</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >44.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Married</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >30.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Divorced</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >20.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Widower</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Surroundings</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Lives with family (spouse, parent, uncle, child)</td><td align="center" valign="middle" >117</td><td align="center" valign="middle" >58.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Lives alone</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >38.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Lives with friends</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Number of children</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >0 - 2</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >71.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >3 - 5</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >24.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >≥6</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Level of study</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Primary</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >39.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >College</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >36.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >High School</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >10.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Not in school</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >8.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >University</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Housing</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Sustainable (family/rental)</td><td align="center" valign="middle" >135</td><td align="center" valign="middle" >67.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Provisional</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >28.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Homeless</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. HUM Family Situation</title><p>The HUM had their father deceased in 70.5% of cases and their mother deceased in 55.0% of cases. Before their death, the parents were living together in 68.0% of cases. The average number of siblings was 7.76 &#177; 4.98. In the HUM family, 16.5% of siblings, 7.5% of fathers and 2.0% of mothers were drug users. Hypertension accounted for 4.5% of the HUM family. <xref ref-type="table" rid="table2">Table 2</xref> summarises the family situation of the HUM.</p></sec><sec id="s3_3"><title>3.3. Legal Aspects</title><p>One hundred and nineteen HUM (59.5%) had a history of incarceration and of these, 71.4% were incarcerated for drug use and possession. During the study period, 198 people (99.0%) had no ongoing judicial problems; one person (0.5%) was under judicial supervision and another person (0.5%) was on provisional release. <xref ref-type="table" rid="table3">Table 3</xref> summarises all legal aspects.</p></sec><sec id="s3_4"><title>3.4. Addictive Behaviours</title><p>One hundred and fifty-one HUM (75.5%) stayed abroad at least once. Ghana was the country of stay in 60.9% of cases. One hundred and five HUM (52.5%) started using drugs abroad. Cannabis, tobacco and cocaine were the other drugs associated with heroin use in 79.5%, 74.5% and 59.5% of cases respectively. In order to obtain drugs directly or to find the financial means to buy the drugs, 5.0% of the HUM had opted for sex work. In terms of the age at which drug use began, the 20 - 30 age group accounted for almost half of the patients for all drugs (heroin 51.0%, cannabis 47.2%, tobacco 47.0%, cocaine 52.1% and alcohol 46.7%). <xref ref-type="table" rid="table4">Table 4</xref> and <xref ref-type="table" rid="table5">Table 5</xref> give a summary of the addictive behaviours.</p></sec><sec id="s3_5"><title>3.5. Medical Aspects</title><p>A history of overdose accounted for 18.0% of the HUM in our sample. Twenty-nine HUM (14.5%) had a history of addiction treatment and 19.5% had attempted suicide. Tuberculosis had been detected in 5.5% of the HUM in our sample. HIV accounted for 3.0% of our HUM. <xref ref-type="table" rid="table6">Table 6</xref> summarises all medical aspects.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of HUM by family status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th><th align="center" valign="middle" >Workforce (n = 200)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fathers’ situation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Deceased father</td><td align="center" valign="middle" >141</td><td align="center" valign="middle" >70.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Living father</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >25.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Unknown father</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Status of mothers</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Deceased mother</td><td align="center" valign="middle" >110</td><td align="center" valign="middle" >55.0</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Living Mother</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >42.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mother unknown</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Missing mother</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Parents’ married life</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Living together</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >68.0</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Divorced or separated</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >32.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Siblings</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >[0 - 5[</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >41.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >[5 - 10[</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >33.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >[10 - 15[</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >16.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >[15 - 20[</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >6.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >[20 and over[</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Siblings with addiction problems</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >167</td><td align="center" valign="middle" >83.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Yes</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >16.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Father’s addiction problem</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >185</td><td align="center" valign="middle" >92.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Yes</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Addiction problem in the mother</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >196</td><td align="center" valign="middle" >98.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Yes</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Family medical history</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >High blood pressure</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Diabetes</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Asthma</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Stroke</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Breast cancer</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Sickle cell disease</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of HUM by legal aspects</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Previous incarceration (n = 200)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >59.5</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >40.5</td></tr><tr><td align="center" valign="middle" >Time of incarceration (n = 119)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >During the addiction</td><td align="center" valign="middle" >117</td><td align="center" valign="middle" >98.3</td></tr><tr><td align="center" valign="middle" >Before the addiction</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.7</td></tr><tr><td align="center" valign="middle" >Number of incarcerations (n = 119)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >64.7</td></tr><tr><td align="center" valign="middle" >2 - 3</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >32.8</td></tr><tr><td align="center" valign="middle" >4 - 5</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >Total time in prison (n = 119)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Less than 1 year</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >83.2</td></tr><tr><td align="center" valign="middle" >1 to 2 years</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >10.1</td></tr><tr><td align="center" valign="middle" >More than 2 years</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.7</td></tr><tr><td align="center" valign="middle" >Reason for imprisonment (n = 119)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Drug use and possession</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >71.4</td></tr><tr><td align="center" valign="middle" >Flight</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >13.4</td></tr><tr><td align="center" valign="middle" >Drug trafficking</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >Abuse of trust</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.7</td></tr><tr><td align="center" valign="middle" >Fighting</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.7</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >9.2</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Of Socio-Demographic Aspects</title><p>In our study, males predominated among HUM at 90.5% of cases, i.e. a sex ratio of 9.5. This over-representation of men among drug addicts has already been found in the sub-Saharan literature [<xref ref-type="bibr" rid="scirp.116325-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref9">9</xref>]. For example, at CEPIAD in Dakar, men were in the vast majority (93.65%) in the study by Ciss&#233; Diallo et al. [<xref ref-type="bibr" rid="scirp.116325-ref7">7</xref>]. This male predominance found in this south of the African Sahara context could be explained by the intense activity of men, especially in the informal sector, in order to earn more money [<xref ref-type="bibr" rid="scirp.116325-ref4">4</xref>]. It must also be said that in this south of the African Sahara environment, men’s misguidance is more tolerated than that of women, who must, according to the culture, remain a model for the family. Through their role as educating mothers, women convey values of good morals. This can make women embarrassed to recognise their addiction and ask for help.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of HUM according to addictive behaviours</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Workforce</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Notion of staying abroad (n = 200)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >151</td><td align="center" valign="middle" >75.5</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >24.5</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Main countries of stay (n = 151, combination of several countries possible)</td></tr><tr><td align="center" valign="middle" >Ghana</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >60.9</td></tr><tr><td align="center" valign="middle" >Benin</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >37.7</td></tr><tr><td align="center" valign="middle" >Ivory Coast</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >22.5</td></tr><tr><td align="center" valign="middle" >Nigeria</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >16.5</td></tr><tr><td align="center" valign="middle" >Burkina Faso</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >13.2</td></tr><tr><td align="center" valign="middle" >France</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4.6</td></tr><tr><td align="center" valign="middle" >Germany</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >Mali</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >Cameroon</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Niger</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Senegal</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.3</td></tr><tr><td align="center" valign="middle" >Place of drug initiation (n = 200)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Foreign</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >52.5</td></tr><tr><td align="center" valign="middle" >Togo</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >47.5</td></tr><tr><td align="center" valign="middle" >Origin of the request for care (n = 200)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Family and friends</td><td align="center" valign="middle" >134</td><td align="center" valign="middle" >67.0</td></tr><tr><td align="center" valign="middle" >Field Team</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >19.0</td></tr><tr><td align="center" valign="middle" >HUM itself</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >14.0</td></tr><tr><td align="center" valign="middle" >Type of application (n = 200)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Weaning</td><td align="center" valign="middle" >157</td><td align="center" valign="middle" >78.5</td></tr><tr><td align="center" valign="middle" >Substitution</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >21.5</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Other drugs used (n = 200, combination of several drugs possible)</td></tr><tr><td align="center" valign="middle" >Cannabis</td><td align="center" valign="middle" >159</td><td align="center" valign="middle" >79.5</td></tr><tr><td align="center" valign="middle" >Tobacco</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >74.5</td></tr><tr><td align="center" valign="middle" >Cocaine</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >59.5</td></tr><tr><td align="center" valign="middle" >Alcohol</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >Crack</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >13.0</td></tr><tr><td align="center" valign="middle" >Misuse of drugs (benzodiazepine, codeine, tramadol, amphetamine, promethazine)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.0</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of HUM according to the characteristics of their addictive behavior</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Heroin (n = 200)</th><th align="center" valign="middle" >Cannabis (n = 159)</th><th align="center" valign="middle" >Tobacco (n = 149)</th><th align="center" valign="middle" >Cocaine (n = 119)</th><th align="center" valign="middle" >Alcohol (n = 75)</th></tr></thead><tr><td align="center" valign="middle"  colspan="6"  >Starting age (in years)</td></tr><tr><td align="center" valign="middle" >[10 - 20[</td><td align="center" valign="middle" >42 (21.0%)</td><td align="center" valign="middle" >51 (32.1%)</td><td align="center" valign="middle" >45 (30.2%)</td><td align="center" valign="middle" >25 (21.0%)</td><td align="center" valign="middle" >29 (38.7%)</td></tr><tr><td align="center" valign="middle" >[20 - 30[</td><td align="center" valign="middle" >102 (51.0%)</td><td align="center" valign="middle" >75 (47.2%)</td><td align="center" valign="middle" >70 (47.0%)</td><td align="center" valign="middle" >62 (52.1%)</td><td align="center" valign="middle" >35 (46.7%)</td></tr><tr><td align="center" valign="middle" >[30 - 40[</td><td align="center" valign="middle" >40 (20.0%)</td><td align="center" valign="middle" >26 (16.3%)</td><td align="center" valign="middle" >25 (16.8%)</td><td align="center" valign="middle" >23 (19.3%)</td><td align="center" valign="middle" >7 (9.3%)</td></tr><tr><td align="center" valign="middle" >[40 - 50[</td><td align="center" valign="middle" >16 (8.0%)</td><td align="center" valign="middle" >7 (4.4%)</td><td align="center" valign="middle" >9 (6.0%)</td><td align="center" valign="middle" >9 (7.6%)</td><td align="center" valign="middle" >4 (5.3%)</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Mode of consumption</td></tr><tr><td align="center" valign="middle" >Smoked</td><td align="center" valign="middle" >103 (51.5%)</td><td align="center" valign="middle" >159 (100%)</td><td align="center" valign="middle" >145 (97.3%)</td><td align="center" valign="middle" >106 (89.1%)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Injected</td><td align="center" valign="middle" >97 (48.5%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >10 (8.4%)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Chewed</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >3 (2.0%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Inhaled (snorted)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (0.7%)</td><td align="center" valign="middle" >3 (2.5%)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Frequency</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Every day</td><td align="center" valign="middle" >199 (99.5%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >119 (100%)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Once a week</td><td align="center" valign="middle" >1 (0.5%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Number of drinks, cigarettes or joints per day</td></tr><tr><td align="center" valign="middle" >[0 - 5[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >100 (62.9%)</td><td align="center" valign="middle" >15 (10.1%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >60 (80.0%)</td></tr><tr><td align="center" valign="middle" >[5 - 10[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >33 (20.8%)</td><td align="center" valign="middle" >30 (20.1%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >11 (14.7%)</td></tr><tr><td align="center" valign="middle" >[10 - 15[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >17 (10.7%)</td><td align="center" valign="middle" >20 (13.4%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >3 (4.0%)</td></tr><tr><td align="center" valign="middle" >[15 - 20[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >9 (5.7%)</td><td align="center" valign="middle" >17 (11.4%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (1.3%)</td></tr><tr><td align="center" valign="middle" >[2 - 250[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >41 (27.5%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >[25 - 30[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >20 (13.4%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >[30- and more[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >6 (4.1%)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Number of drunkenness per Month</td></tr><tr><td align="center" valign="middle" >[0 - 10[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >69 (92.0%)</td></tr><tr><td align="center" valign="middle" >[10 - 20[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >4 (5.3%)</td></tr><tr><td align="center" valign="middle" >[20 - 30[</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >2 (2.7%)</td></tr></tbody></table></table-wrap><p>The average age of the HUM in our study was 43.4 &#177; 9.6 years, with a predominance of the 45 to 54 age group (41.5%). Taking into account the age of the start of drug use, which for almost half of the HUM was between 20 and 30 years, we can say that the drug users started in adolescence or young adulthood and experienced between 10 and 20 years of drug use before seeking help for withdrawal. The young age of onset of drug use has already been reported by several authors [<xref ref-type="bibr" rid="scirp.116325-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref12">12</xref>].</p><p>As the level of education was low in our study (8.5% not attending school, primary school 39.0%, secondary school 36.0%), we can say that these HUM had</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of HUM by medical aspects</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Workforce</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >History of overdose</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle"  colspan="2"  >164</td><td align="center" valign="middle" >82.0</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle"  colspan="2"  >36</td><td align="center" valign="middle" >18.0</td></tr><tr><td align="center" valign="middle"  colspan="4"  >History of addiction treatment</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle"  colspan="2"  >164</td><td align="center" valign="middle" >85.5</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle"  colspan="2"  >29</td><td align="center" valign="middle" >14.5</td></tr><tr><td align="center" valign="middle"  colspan="4"  >History of suicide attempt</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle"  colspan="2"  >161</td><td align="center" valign="middle" >80.5</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle"  colspan="2"  >39</td><td align="center" valign="middle" >19.5</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Previous psychiatric hospitalization</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle"  colspan="2"  >194</td><td align="center" valign="middle" >97.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Yes</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Psychiatric comorbidities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >No comorbidities</td><td align="center" valign="middle" >180</td><td align="center" valign="middle" >90.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Depressive disorders</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Psychotic disorders</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Personality disorder</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Anxiety disorders</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Somatic comorbidities (combination of several comorbidities possible)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >No comorbidities</td><td align="center" valign="middle" >165</td><td align="center" valign="middle" >82.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Tuberculosis</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Gastric and/or duodenal ulcer</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >HIV</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Sexually transmitted disease</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Asthma</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >High blood pressure</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Hepatitis B or C</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Heart disease</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Tooth decay</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Cataract</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Low back pain</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Diabetes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Hemorrhoidal disease</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>not understood the awareness messages. It is only when faced with the complications of their addictions that they would have sought care. We can also say that since their addictions started very early in adolescence, they would have prevented them from developing at school.</p><p>In our study, single people accounted for 44.0% of cases. This is a low proportion compared to the result of M’bongo’o et al. [<xref ref-type="bibr" rid="scirp.116325-ref10">10</xref>] in Cameroon. In their study, singles represented 96% of their sample. It must be said that their study population was made up of pupils and students in two thirds of cases. The celibacy of our HUM could be explained by the fact that drug use can lead to marginalisation, which turns the individual away from marriage and/or encourages the separation of couples.</p></sec><sec id="s4_2"><title>4.2. Of Addictive Behaviours and Legal Aspects</title><p>Trafficking, possession and use of illicit drugs are not yet decriminalised in Togo, which explains the history of incarceration among 59.5% of the HUM in our sample. In 71.4% of cases, they said they had been imprisoned for drug use and possession. We also say that addictive behaviour leads to repressive acts such as theft, rape, physical aggression and even homicide.</p><p>In our study, cannabis, tobacco and cocaine were the other drugs associated with heroin use in 79.5%, 74.5% and 59.5% of cases respectively, making our study population poly addicts. The use of several drugs at the same time had already been found in some Togolese studies [<xref ref-type="bibr" rid="scirp.116325-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.116325-ref8">8</xref>]. In Abidjan, in the study by Tigori-Sangar&#233; et al. [<xref ref-type="bibr" rid="scirp.116325-ref12">12</xref>], polyaddiction use represented 10.2% of their sample.</p></sec><sec id="s4_3"><title>4.3. Of Medical Aspects</title><p>Suicide attempts accounted for 19.5% of the HUM in our sample. Exhausted by the difficulties of daily life linked to heroin dependence or polyaddiction, addicts sometimes attempt to end their lives by any means, including overdose. This may partly justify the 18.0% of our patients who have a history of overdose. But it should also be added that the loss of control over the product can also justify overdoses.</p><p>Tuberculosis had been detected in 5.5% of the HUM in our sample. Our proportion of tuberculosis patients is higher than that of the study by Ciss&#233; Diallo et al. [<xref ref-type="bibr" rid="scirp.116325-ref7">7</xref>] in Dakar at CEPIAD, which found 1.68% of tuberculosis patients. HIV seroprevalence among the HUM in our sample was 3%. This is slightly higher than the prevalence of HIV in the general population of Togo, which is 2.3% [<xref ref-type="bibr" rid="scirp.116325-ref13">13</xref>]. We are still below the 5% HIV prevalence found in the study by Ciss&#233; Diallo et al. [<xref ref-type="bibr" rid="scirp.116325-ref7">7</xref>] in Dakar at CEPIAD. Our low proportion of HIV among the HUM is linked to the fact that we had very few heroin injectors in our sample. Nevertheless, these HUM are among the key populations in the fight against HIV and should benefit from appropriate programmes because heroin addiction often leads to HIV risk behaviours such as unprotected sex, sex work and needle sharing among heroin injectors.</p></sec><sec id="s4_4"><title>4.4. Strengths and Weaknesses of Our Study</title><p>Our study, a cross-sectional and descriptive study conducted from December 1st, 2020 to January 31, 2021 at the CEPIAK, focuses on heroin users on methadone substitution (HUM). This category of addicts was regular in taking methadone on a daily basis and the information collected in this population was reliable, verifiable and thus constituted a strength for our study. The weakness of our study lies in the fact that it cannot be generalized to all heroin users in the city of Lom&#233;. Indeed, our study did not take into account heroin users who were not yet receiving methadone substitution.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>As in other West African countries, drug-related problems have increased in Togo. In order to provide comprehensive care that takes into account the reduction of the risk of exposure to HIV and the management of addiction, Togo has welcomed the CEPIAK in 2019. Given the absence of a study on the activities of the centre, we felt it necessary to conduct this study. At the end of this study, the male gender predominated at almost ten times the number of women. Young adults were in the majority. The HUM had a low level of education. HIV seroprevalence among HUM was slightly higher than in the general population of Togo. Cannabis, tobacco and cocaine were the other drugs commonly associated with heroin use. It is important that the Togolese health system should give more importance to this issue, which is shared between the medical and societal sectors, in order to effectively reduce and prevent these social ills.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our thanks go to the PNLS coordinator and the OCAL coordinator who authorized this study. Our thanks also go to all the CEPIAK staff who facilitated this study.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s8"><title>Cite this paper</title><p>Salifou, S., Kanekatoua, S., Wenkourama, D., Ekpai, E., Affo, C., Awoussi, Y.A., Dassa, K.S. (2022) Characteristics of Heroin Users in Lom&#233; (Togo). Open Journal of Psychiatry, 12, 141-156. https://doi.org/10.4236/ojpsych.2022.122012</p></sec><sec id="s9"><title>Survey Form</title><p>1) SIGNALING MODULE</p><p>Age: ......... Gender: □ Male □ Female Profession:......... Nationality: ...............</p><p>Marital status</p><p>□ Single □ Monogame □ Polygamis □ Common □ Widow □ Divorced</p><p>Sexual orientation</p><p>□ Heterosexuality □ Homosexuality □ Bisexuality □ Transsexuality</p><p>Childhood</p><p>□ No problem □ Difficult □ Abandon □ Placement □ Other..................</p><p>Environment</p><p>□ Lives with spouse only □ Lives with his friends □ Lives with spouse and children</p><p>□ Lives with parents □ Lives alone with children □ Lives alone</p><p>Number of children:..............................</p><p>Professional situation: (During the last 6 months)</p><p>□ Formal □ Housewife □ Student □ Unemployment □ Employment □ Informal Other…………………………………</p><p>Education Level:</p><p>□ No school □ Primary □ College □ High □ University</p><p>Housing</p><p>□ Sustainable independent □ Sustainable family □ Temporary at clos □ Temporary at other □ Homeless □ others……………..</p><p>2) LEGAL MODULE</p><p>Current legal situation</p><p>□ Not applicable □ Probation □ Semi-freedom □ Judicial review</p><p>□ Provisional □ care order □ Duty of care □ Others………………</p><p>Previous incarceration □ Yes □ No</p><p>If “yes”, specify:</p><p>□ Before □ During addiction □ Before addiction and During addiction</p><p>Number of incarcerations: ....... Total length of incarceration: ................</p><p>Reason for last incarceration</p><p>□ drug trafficking □ Drug possession □ Theft □ Drug use □ Others……</p><p>Civil Litigation: □ Yes □ No</p><p>If “yes”, specify: □ Divorced □ Parental authority □ Debt □ Other.........</p><p>3) ANTECEDENT MODULE</p><p>a) Personal History</p><p>Sex for money or drugs or other material benefits at least once in a lifetime</p><p>□ Yes □ No</p><p>Sexual intercourse unwanted by the person and consented to under moral or physical threat at least once in his/her life □ Yes □ No</p><p>Sexual intercourse with other partners in the past 6 months □ Yes □ No</p><p>Sexually transmitted infection in the last 12 months □ Yes □ No</p><p>HIV □ Yes □ NoIf “yes”, please specify □ 1 □ 2 □ 1 and 2</p><p>Hepatitis B □ Yes □ No Hepatitis C □ Yes □ No</p><p>Addictology care □ Yes □ NoIf “yes”, specify the number of times: ..........</p><p>Other comorbidities</p><p>□ HTA □ Diabetes □ Asthma □ Sicklecell □ Allergy □Obesity</p><p>Staying abroad: □ Yes □ No If “yes”, specify the country ..............</p><p>Start of drug useabroad □ Yes □ No</p><p>If female, specify □ Gravidity.......................... □ Parity...........................</p><p>Main resources to obtain the drug</p><p>□ Employment income (including retirement anddisability pension) □ Theft</p><p>□ Begging □ At the expense of athird □ Scam □ Sexwork</p><p>b) Family history</p><p>Parents’ marriedLife</p><p>□ Together □ Separated □ Divorced □ Other situations……...;</p><p>Addiction problem in siblings □ Yes □ No</p><p>Father’s addiction problem □ Yes □ No</p><p>Mother’s addiction problem □ Yes □ No</p><p>PARENTS’ STATUS</p><p>Father Mother</p><p>Living □ □</p><p>Unknow □ □</p><p>Missing □ □</p><p>Deceased □ □</p><p>PARENTS’ PROFESSIONALSITUATION</p><p>Father Mother</p><p>In operation □ □</p><p>Unemployement □ □</p><p>Retirement □ □</p><p>Invalidity □ □</p><p>Unkown □ □</p><p>Number of children in the family: ......... Rank in siblings: .......................</p><p>Pathologies in the family: ...........................................</p><p>4) ADDICTION MODULE</p><p>Medical coverage □ Yes □ No</p><p>Origin of the request for care</p><p>□ Patient himself □ Family/Friend □ City doctor □ Other Hospital/health structure □ Specialized structure in psychiatry/addiction □ Community structure □ Field Team □ School/university □ Judicial or administrative measure □ Other .................</p><p>Main type of request</p><p>□ Weaning □ Consumption reduction □ Substitution □ Post cure □ Health-chek</p><p>Alcohol consumption □ Yes □ No</p><p>If “yes”, specify:</p><p>□ Starting age .......... □ Number of glasses/days □ Number of drunkenness /months .......</p><p>Tobacco consumption □ Yes □ No</p><p>□ Starting age ................ □ Consumption mode.......... □ Number of cigarettes/day .... .......</p><p>Cannabis use □ Yes □ No</p><p>If “yes”, specify:</p><p>□ Starting age ................ □ Consumption mode.......... □ Number of joint/day</p><p>Cocaine use □ Yes □ No</p><p>If “yes”, specify:</p><p>□ Starting age ................ □ Consumption mode............ □ Frequency.................</p><p>Heroin use □ Yes □ No</p><p>If “yes”, specify:</p><p>Starting age ............... Frequency............</p><p>Consumption of Tramadol □ Yes □ No</p><p>If “yes”, specify:</p><p>□ Starting age ................ □ Consumption mode............ □ Frequency.................</p><p>If using Heroin and/or Tramadol, specify:</p><p>IV injection: □ Yes □ No</p><p>If “yes”, specify:</p><p>Needle sharing: □ Yes □ No</p><p>Consumption of other products</p><p>□ Yes □ No</p><p>If “yes”, specify:</p><p>1. Product name...............2. Starting age……..3. Consumption mode............ 4. Frequency..........</p><p>Status in relation to the current support substance</p><p>□ Not weaned □ Weaning in □ Weaning done □ Substitution</p><p>History of overdose □ Yes □ No</p><p>If “yes”, specify month and year of last overdose: .....................</p><p>History of suicide attempt</p><p>□ Since addiction □ Before addiction □ Absent</p><p>History of hospitalization in a psychiatric ward □ Yes □ No</p><p>If “yes”, specify:</p><p>1). Number of hospitalizations…2). Month and Year of last hospitalization .....</p><p>Psychiatric Comorbidities</p><p>□ No comorbidities □ Eating disorders □ Depressive disorders</p><p>□ Psychotic and delusional disorders □ Personnality disorder</p><p>□ bipolar disorder □ Anxiety disorders □ Other disorders</p><p>Current medical treatment □ Yes □ No</p><p>If “yes”, specify</p><p>□ Neuroleptics □ Thymoregulators □ upropion □ Nicotinics</p><p>□ Anxiolytics □ Antabuse □ Acamprosate □ Substitutes □ Natrelxone</p><p>□ Hypnotics □ Antidepressants □ Others………</p></sec></body><back><ref-list><title>References</title><ref id="scirp.116325-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2017) Rapport mondial sur les drogues 2017. Office des Nations unies contre la drogue et le crime.</mixed-citation></ref><ref id="scirp.116325-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">WACD (2014) Not Just in Transit: Drugs, the State and Society in West Africa. West Africa Commission on Drugs Accra, Ghana, 68 p.</mixed-citation></ref><ref id="scirp.116325-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nubukpo</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>Les addictions en Afrique subsaharienne</article-title><source> Le Courrier des addictions</source><volume> 13</volume>,<fpage> 27</fpage>-<lpage>30</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.116325-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Salifou, S., Ekpa&amp;#239, E., Wenkourama, D., Kanekatoua, S., Affo, C. and Dassa, K.S. (2021) Facteurs associés à la consommation de substances psychoactives par les conducteurs de taxi-moto à Lomé. Health Sciences and Disease, 22, 63-67.</mixed-citation></ref><ref id="scirp.116325-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Eiden, C., Léglise, Y., Bertomeu, L., Clavel, V., Faillie, J.L., Petit, P., et al. (2013) New Formulation of Methadone for Opioid Dependence in France: Acceptability and Diversion/Misuse Liability. Therapie, 68, 107-111. https://doi.org/10.2515/therapie/2013020</mixed-citation></ref><ref id="scirp.116325-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Dupouy, J., Bez, J., Barsony, J., Oustric, S. and Lapeyre-Mestre, M. (2013) Cycles de traitement par médicament de substitution aux opiacés dans une cohorte de patients suivis 5 ans en médecine ambulatoire. Therapie, 68, 155-61. https://doi.org/10.2515/therapie/2013022</mixed-citation></ref><ref id="scirp.116325-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Cissé Diallo, V.M.P., Ndiaye, I., Ba, I., et al. (2018) Comorbidités somatiques au Centre de prise en charge intégrée des addictions de Dakar (CEPIAD), premier centre d’Afrique de l’Ouest. Revue Africaine et Malgache pour la Recherche Scientifique/Sciences de la Santé, 1, 28-31.</mixed-citation></ref><ref id="scirp.116325-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ekouevi, D.K., Coffie, P.A., Salou, M., Kariyiare, B.G., Dagnra, A.C., Tchounga, B., Prince-David, M., Becquet, R., Pitche, V.P. (2013) Séroprévalence du VIH chez les usagers de drogues au Togo. Santé Publique, 4, 491-498. https://doi.org/10.3917/spub.134.0491</mixed-citation></ref><ref id="scirp.116325-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Djidonou, A., Tognon Tchégnonsi, F., Gansou, G.M., Ata&amp;#239gba, I.N.E., Babaèkpa, K.R., Hers, D., et al. (2015) Prévalence et facteurs associés à l’addiction au Tramadol chez les conducteurs de taxi-motos (Zé) à Parakou/Bénin. Bénin Medical, 60/61, 7-13.</mixed-citation></ref><ref id="scirp.116325-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">M’bongo’o, G.C., Okoto Mvondo, N., Fogang Fogoum, Y., et al. (2021) Profils sociodémographiques et comorbidités des usagers en consultation d’addictologie à Yaoundé. Health Sciences and Disease, 22, 35-41.</mixed-citation></ref><ref id="scirp.116325-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pefura-Yone, E.W., Balkissou, A.D., Theubo-Kamgang, B.J., Afane-Ze, E. and Kuaban, C. (2016) Prévalence et facteurs associés au tabagisme à Yaoundé, Cameroun. Health Sciences and Disease, 17, 48-52. https://doi.org/10.1016/j.rmr.2014.10.404</mixed-citation></ref><ref id="scirp.116325-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tigori-Sangaré, B., Djédjé Dano, S., Vallée-Polneau, S., Agbaya Oga, S. and Kouadio, L. (2011) Consommation de substances psycho-actives et profil des usagers à Abidjan (C&amp;#244te-d’Ivoire) en 2009. Revue francophone des laboratories, 436, 59-61. https://doi.org/10.1016/S1773-035X(11)71156-X</mixed-citation></ref><ref id="scirp.116325-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Progrmme National de Lutte contre le Sida (2018) Situation épidémiologique 2018. https://pnls.tg/PNLS01/situation-epidemiologique/</mixed-citation></ref></ref-list></back></article>